Recent advances in physicochemical and ADMET profiling in drug discovery

Chemistry & Biodiversity
Jianling Wang, Suzanne Skolnik

Abstract

The drastic increase in the cost for discovering and developing a new drug along with the high attrition rate of development candidates led to shifting drug-discovery strategy to parallel assessment of comprehensive drug physicochemical, and absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties alongside efficacy. With the proposal of a profiling paradigm and utilization of integrated risk assessment, one can exponentially enhance the predictive power of in vitro tools by taking into consideration the interplay among profiling parameters. In particular, this article will review recent advances in accurate assessment of solubility and other physicochemical parameters. The proper interpretation of these experimental data is crucial for rapid and meaningful risk assessment and rational optimization of drug candidates in drug discovery. The impact of these tools on assisting drug-discovery teams in establishing in vitro-in vivo correlation (IVIVC) as well as structure-property relationship (SPR) will be presented.

References

Aug 24, 2000·Journal of Medicinal Chemistry·F LombardoM H Abraham
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J B Dressman, C Reppas
Oct 29, 2000·Journal of Medicinal Chemistry·W J EganJ J Baldwin
Feb 24, 2001·Pharmaceutical Research·L HitzelK L Locker
Dec 18, 2001·Journal of Pharmaceutical Sciences·E H Kerns
Mar 12, 2002·Pharmaceutical Research·Christel A S BergströmPer Artursson
Mar 20, 2002·Current Topics in Medicinal Chemistry·A Avdeef
Jun 28, 2002·Journal of Chemical Information and Computer Sciences·Igor V Tetko
Jul 13, 2002·Journal of Pharmaceutical Sciences·Xue-Qing ChenSrini Venkatesh
Feb 21, 2003·Journal of Medicinal Chemistry·Agnes Taillardat-BertschingerBernard Testa
Mar 8, 2003·Analytical Chemistry·Karl BoxDerek Reynolds
Oct 8, 2003·Mini Reviews in Medicinal Chemistry·Igor V Tetko
Dec 4, 2003·Rapid Communications in Mass Spectrometry : RCM·Hong WanRichard A Thompson
Feb 26, 2004·The Journal of Pharmacy and Pharmacology·Edmund S KostewiczJennifer B Dressman
Jul 22, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Christel A S BergströmPer Artursson
Oct 7, 2004·European Journal of Pharmacology·Keith FinlaysonJohn Sharkey
Nov 24, 2004·Pharmaceutical Research·Xue-Qing Chen, Srini Venkatesh
Jan 5, 2005·Journal of Chromatography. a·Roman KaliszanMichał J Markuszewski
Apr 2, 2005·Journal of Medicinal Chemistry·Bernard FallerXavier Briand
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·V Hayden ThomasAyman El-Kattan
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Hong Wan, Johan Ulander
Aug 18, 2006·Journal of Medicinal Chemistry·Craig JamiesonGrant Wishart
Oct 5, 2006·Mini Reviews in Medicinal Chemistry·A LahozM J Gómez-Lechón
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Bernard FallerLaszlo Urban
Jan 24, 2007·Bioorganic & Medicinal Chemistry Letters·Michael J Waring, Craig Johnstone
Mar 21, 2007·Pharmaceutical Research·Maria VertzoniChristos Reppas
Jun 2, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Francesco BarbatoMaria Immacolata La Rotonda
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·Jianling WangDejan Bojanic
Nov 1, 2007·Nature Reviews. Drug Discovery·Paul D Leeson, Brian Springthorpe
Jun 17, 2008·Journal of Pharmaceutical Sciences·Costas Giaginis, Anna Tsantili-Kakoulidou
Nov 1, 2007·Expert Opinion on Drug Discovery·David E Clark

❮ Previous
Next ❯

Citations

Aug 13, 2013·International Journal of Pharmaceutics·Benjamin WuytsPatrick Augustijns
Mar 23, 2011·Expert Opinion on Drug Metabolism & Toxicology·Jianling Wang, Alan Collis
Dec 17, 2014·Journal of Chemical Information and Modeling·Robert FraczkiewiczAlexander Hillisch
Jan 18, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Su Mi ChoiYoon-Young Jang
Jun 19, 2012·European Journal of Medicinal Chemistry·Alexandra GasparFernanda Borges
Nov 21, 2013·Biomacromolecules·Kristopher J KoudelkaMarianne Manchester
Jun 1, 2013·Molecular Informatics·Hai Pham-TheMiguel Ángel Cabrera-Pérez
Feb 20, 2021·Clinical and Translational Science·Hualou LiangHongbin Wang
Sep 21, 2010·Bioorganic & Medicinal Chemistry Letters·Hong Chul YoonGyoonhee Han
Jun 29, 2010·Journal of Chemical Information and Modeling·Jie ShenYun Tang
Jul 12, 2019·Chemical Reviews·Xin YangShengyong Yang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.